Also Known as Clobex, Dermovate
Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
0.05% 30g
|
|||
Strength
0.05% 50g
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Temovate relieves inflammatory skin conditions, offering symptomatic relief and improving the quality of life. Careful monitoring for potential side effects and adherence to usage instructions are essential to ensure this medication's safe and appropriate use.
Temovate is a potent topical corticosteroid medication used to treat various inflammatory skin conditions. Its active ingredient is clobetasol propionate, which belongs to the corticosteroid class.
Clobetasol reduces inflammation, itching, and redness associated with conditions such as eczema, psoriasis, dermatitis, and other skin disorders. Temovate is available in several forms, including cream, ointment, and foam, and is applied directly to the affected areas of the skin.
Fact Table | |
---|---|
Formula | C25H32ClFO5 |
License | FDA approved |
Bioavailability | Minimal systemic absorption when used topically |
Legal status | Prescription only |
Chemical Name | Clobetasol propionate: 21-chloro-9-fluoro-11ß,17-dihydroxy-16ß-methylpregna-1,4-diene-3,20-dione 17-propionate |
Elimination half-life | Not well-defined for topical use |
Dosage (Strength) | 0.05% cream |
Pregnancy | Category C; consult a healthcare provider |
Brands | Temovate, Clobex, Olux, Dermovate |
Protein binding | High, but specific data not well-defined |
PubChem CID | 5311054 |
MedlinePlus | a682366 |
ChEBI | 5989 |
ATC code | D07AD01 |
DrugBank | DB01013 |
KEGG | D00945 |
Routes of administration | Topical |
Apply a small amount to the affected area(s) once or twice daily as directed by your healthcare provider.
Wash hands thoroughly with soap and water after each application. Do not get Temovate into the eyes, mouth, nose, or other mucous membranes.
Do not take Temovate for longer than directed by your healthcare provider because it can lead to adverse reactions.
The active ingredient in Temovate is clobetasol.
Tell your doctor or pharmacist if you are taking any of the following:
Use caution if you have a history of hypersensitivity to corticosteroids or other ingredients in the formulation.
Long-term use or excessive application of Temovate may increase the risk of adverse effects such as skin thinning, stretch marks, and systemic absorption of the medication.
It is not recommended for use on the ground, face, or underarms unless directed by a healthcare provider.
Common adverse reactions to this drug may include:
Temovate [package insert]. Research Park Triangle, NJ: GlaxoSmithKline; 2003.